Cary Street Partners Investment Advisory’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$229K Sell
4,957
-310
-6% -$14.4K 0.11% 204
2025
Q1
$321K Buy
5,267
+830
+19% +$50.6K 0.19% 139
2024
Q4
$251K Sell
4,437
-41,798
-90% -$2.36M 0.16% 141
2024
Q3
$2.39M Sell
46,235
-43,683
-49% -$2.26M 0.09% 244
2024
Q2
$3.73M Sell
89,918
-3,313
-4% -$138K 0.15% 160
2024
Q1
$5.06M Sell
93,231
-4,947
-5% -$268K 0.21% 126
2023
Q4
$5.04M Sell
98,178
-9,562
-9% -$491K 0.24% 115
2023
Q3
$6.25M Buy
107,740
+7,231
+7% +$420K 0.34% 78
2023
Q2
$6.43M Sell
100,509
-4,666
-4% -$298K 0.41% 60
2023
Q1
$7.29M Buy
105,175
+2,562
+2% +$178K 0.52% 53
2022
Q4
$7.38M Sell
102,613
-708
-0.7% -$50.9K 0.54% 51
2022
Q3
$7.35M Buy
103,321
+666
+0.6% +$47.3K 0.6% 49
2022
Q2
$7.91M Buy
102,655
+62,989
+159% +$4.85M 0.67% 40
2022
Q1
$2.9M Buy
39,666
+15,232
+62% +$1.11M 0.8% 34
2021
Q4
$1.52M Buy
24,434
+1,628
+7% +$101K 0.42% 74
2021
Q3
$1.35M Buy
22,806
+2,051
+10% +$121K 0.44% 70
2021
Q2
$1.39M Buy
20,755
+10,305
+99% +$689K 0.45% 68
2021
Q1
$660K Sell
10,450
-15,305
-59% -$967K 0.27% 94
2020
Q4
$1.6M Sell
25,755
-54,382
-68% -$3.37M 0.31% 84
2020
Q3
$4.83M Buy
80,137
+75,754
+1,728% +$4.57M 1.02% 19
2020
Q2
$257K Hold
4,383
0.36% 86
2020
Q1
$244K Buy
4,383
+235
+6% +$13.1K 0.57% 51
2019
Q4
$266K Buy
+4,148
New +$266K 0.29% 96